ISSN:
1432-1041
Schlagwort(e):
Propranolol
;
atenolol
;
hypertension
;
cardio-selective
;
beta-adrenergic blockade
;
antihypertensive therapy
Quelle:
Springer Online Journal Archives 1860-2000
Thema:
Chemie und Pharmazie
,
Medizin
Notizen:
Summary Propranolol was given to 30 patients with essential hypertension following randomised, double-blind administration of either placebo or a new cardioselective beta-adrenergic receptor antagonist, atenolol (Tenormin®, ICI 66 082). Both atenolol and propranolol caused statistically significant reduction of recumbent and erect blood pressure and heart rate. There were no important differences between these variables on comparison of atenolol and propranolol.
Materialart:
Digitale Medien
URL:
http://dx.doi.org/10.1007/BF00606549
Permalink
